Healthcare & Life Sciences
Blank Bio
United States
seed
seed
Stage
2
Investors
About
Blank Bio develops RNA foundation models using applied AI to analyze disease progression and patient responses, aiming to improve clinical trial success rates for pharmaceutical companies by capturing unique tumor biology.
Explore Blank Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.